Funding for this research was provided by:
National Institutes of Health
Received: 9 March 2017
Accepted: 28 August 2017
First Online: 6 September 2017
Ethics approval and consent to participate
: All patients provided written informed consent for participation in the Kamuzu Central Hospital Lymphoma Study, which was approved by the Malawi National Health Sciences Research Committee (Federal Wide Assurance #5976) and University of North Carolina Biomedical Institutional Review Board (Federal Wide Assurance #4801).
: Written consent to publish was obtained from all patients.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.